Total Funding
26
36
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26053
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
Thomas Nagy: Chief Operating OfficerPast Role: Novozymes, Executive Vice President of Stakeholder Relations
About the Company
21st.BIO is a bioproduction startup that assists bioindustrial companies in scaling up from molecule innovation to large-scale production in order to meet market demands and thus advance the global green transition. It helps companies build a competitive manufacturing foundation allowing them to focus on succeeding in the market. Across multiple
expression systems, 21st.BIO provides access to and optimizes high-performance strain platforms and production media improving yields and stability significantly.
